Ocata Therapeutics Inc Share Price OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board
- ^USD	-

10/02/16	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
22/01/16	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
28/12/15	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
03/12/15	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
24/11/15	Ocata Therapeutics : Harwood Feffer LLP : Announces Investigation of Ocata Therapeutics, Inc.	PR

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	02/02/2015

Director	Title	Age	Since
Toru Yoshimitsu BRD	Director/Board Member	63	-
Masaaki Hirano BRD	Director/Board Member	59	-
Percival Barretto-Ko BRD	Director/Board Member	53	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-0.73%	+7.82%	+73.81%	+102.34%	70.1B
ARGENX SE	-0.32%	+0.64%	+37.73%	+65.96%	54.93B
INSMED INCORPORATED	-0.22%	+33.59%	+8.43%	+489.75%	28.89B
WUXI BIOLOGICS (CAYMAN) INC.	+0.04%	+10.49%	+48.44%	+7.45%	23.9B
BIONTECH SE	-0.06%	+0.61%	-16.45%	-13.26%	23.3B
PHARMAESSENTIA CORPORATION	-1.37%	+7.87%	+251.71%	+464.53%	18.41B
GENMAB A/S	-0.49%	+7.94%	+40.94%	-20.08%	18.77B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-0.57%	+3.44%	+25.60%	+619.86%	16.1B
EXELIXIS, INC.	-1.85%	-11.15%	+32.75%	+134.11%	12.48B
Average	-0.62%	+8.38%	+55.88%	+205.63%	29.65B
Weighted average by Cap.	-0.53%	+9.43%	+54.29%	+167.27%

Employees

Sector